41 – 50 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
(
- Contribution to journal › Article
-
Mark
MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial.
(
- Contribution to journal › Article
-
Mark
The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.
(
- Contribution to journal › Letter
- 2014
-
Mark
Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts
(
- Contribution to journal › Article
-
Mark
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
(
- Contribution to journal › Article
- 2013
-
Mark
Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.
(
- Contribution to journal › Article
-
Mark
Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
(
- Contribution to journal › Article